Affiliation:
1. Department of Neuroanaesthesiology, Bangur Institute of Neurosciences, Kolkata, West Bengal, India
Abstract
AbstractHirayama disease (HD) is a rare disease, resulting from cervical compressive myelopathy, manifesting as upper limb muscular atrophy, and rarely autonomic and upper motor neuron signs. Anesthesia management is challenging—careful neck positioning during bag-mask ventilation and endotracheal intubation, avoidance of drugs that release histamine, multimodal monitoring to avoid delayed recovery, anticipation of hypotension, and blood loss due to autonomic dysfunction—all this is necessary for successful outcome of general anesthesia in HD patients. This case series demonstrates that preexisting autonomic dysfunction in HD patients should alert the anesthesiologists regarding higher likelihood of hemodynamic perturbations and blood loss, compared with patients who have normal autonomic functions, and henceforth take appropriate precautionary measures.
Reference10 articles.
1. Anesthetic considerations in Hirayama disease: primum non nocere;J N Monteiro;J Anaesthesiol Clin Pharmacol,2023
2. Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan;K Tashiro;Amyotroph Lateral Scler,2006
3. Monomelic amyotrophy (Hirayama disease) with upper motor neuron signs: a case report;S D Yoo;Ann Rehabil Med,2015
4. [A mechanism of juvenile muscular atrophy localized in the hand and forearm (Hirayama disease)–flexion myelopathy with tight dural canal in flexion];S Kikuchi;Rinsho Shinkeigaku,1987
5. Hirayama disease: a rare disease with unusual features;S Anuradha;Case Rep Neurol Med,2016